Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.34 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.34 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | XBP1 | P17861 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | AADAT | Q8N5Z0 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.31 |
| ▸ | ALDH2 | P05091 | 4/20 | 0.31 |
| ▸ | ALDH3A1 | P30838 | 4/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25119552 | 0.95 | SCN9A (0.37) | CNR1GPR55SCN9A | |
| SCHEMBL25907899 | 0.86 | CNR1 (0.37) | CNR1GPR55SCN9ALMNAKMT2A | |
| SCHEMBL25907919 | 0.78 | USP2 (0.32) | LMNAUSP2HTT | |
| SCHEMBL25907883 | 0.77 | CNR1 (0.54) | CNR1GPR55SCN9ALMNAMEN1 | |
| SCHEMBL25909086 | 0.76 | CNR1 (0.51) | CNR1GPR55SCN9ALMNAMEN1 | |
| SCHEMBL25118979 | 0.76 | CNR1 (0.53) | CNR1GPR55SCN9ALMNAMEN1 | |
| SCHEMBL25907963 | 0.71 | LMNA (0.36) | LMNAMEN1MAPTKMT2AUSP2 | |
| SCHEMBL4597888 | 0.68 | SCN9A (0.71) | SCN9A | |
| SCHEMBL23983398 | 0.67 | CHRM2 (0.34) | CNR1GPR55LMNAMEN1MAPT | |
| SCHEMBL25119457 | 0.64 | ALDH1A1 (0.54) | MAPTNPSR1USP2ALDH1A1ALDH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230244147-A1 | COMPOSITION FOR FORMING ORGANIC FILM, PATTERNING PROCESS, AND COMPOUND AND POLYMER FOR FORMING ORGANIC FILM | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230244147-A1 | COMPOSITION FOR FORMING ORGANIC FILM, PATTERNING PROCESS, AND COMPOUND AND POLYMER FOR FORMING ORGANIC FILM | OR10J3, PYM1, AP1M1 | CNR1 2565/4885GPR55 4460/4885SCN9A 476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.